Drugs in R and D (DRD) is a scholarly journal dedicated to publishing research in the field of Pharmacology, Toxicology and Pharmaceutics, and Published by Springer Nature. The Print-ISSN of Drugs in R and D is 11745886
The Publication fees (APC) is 2690 EUR; 3390 USD; 2290 GBP.
Drugs in R and D is published by Springer Nature, based in United Kingdom, publishing since 2010. It covers research in Pharmacology, Toxicology and Pharmaceutics.
Topics covered include pharmacology, drug development.
The journal is indexed in Scopus, DOAJ; it uses a anonymous peer review process.
Article processing charge: 2690 EUR; 3390 USD; 2290 GBP.
For full aims and scope, see the journal's official page.
| Journal title | Drugs in R and D (DRD) |
| Print ISSN | 11745886 |
| Online ISSN | 11796901 |
| Publisher Name | Springer Nature |
| Subject Category | Pharmacology, Toxicology and Pharmaceutics |
| Access type | 🟢 Open Access |
| Status | 🟢 Active |
In the context of academic journals, "Metrics and Rankings" refer to various measures and evaluations used to assess the quality, influence, and impact of a journal.
Below are the metrics and rankings for the journal Drugs in R and D
| Article Publication Charges (APC) |
2690 EUR; 3390 USD; 2290 GBP ✳️Without APC Pharmacology, Toxicology and Pharmaceutics Journals |
Abstracting and Indexing (A&I) refers to the processes that help organize and categorize academic journals, making them easier to find and access for researchers and scholars
If you would like to submit a manuscript or visit the journal's website, please click on the link below.
| Journal Submission | 🔗 Journal Website |
Add the app to your device for one-tap access.